Ad
related to: abbvie studies
Search results
AbbVie (ABBV) Could Be a Great Choice
Zacks· 5 days agoWhile cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out ...
AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab...
The Parsons Sun· 2 days agoPICCOLO trial met its primary endpoint of objective response rate (ORR)Data from the study will be presented at a future medical meeting
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks· 21 hours agoEli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
ASCO: Replacing chemotherapy with ADCs? AbbVie rebuilds next-gen assets after Rova-T flop
FierceBiotech· 3 days agoA new trend has emerged at this year’s American Society of Clinical Oncology conference: the...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 5 days agoDaejin Abidoye, head of solid tumour oncology, development at AbbVie in an interview with Clinical...
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 4 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology...
Benzinga· 4 days agoAbbVie ABBV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 3 days agoImage source: Getty Images. Which high-yielders stand out as attractive buys heading into this event? Healthcare titans AbbVie (NYSE: ABBV) and Pfizer...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 3 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 15 hours agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
